Transcriptome alterations are enriched for synapse-associated genes in the striatum of subjects with obsessive-compulsive disorder
- PMID: 33723209
- PMCID: PMC7961029
- DOI: 10.1038/s41398-021-01290-1
Transcriptome alterations are enriched for synapse-associated genes in the striatum of subjects with obsessive-compulsive disorder
Abstract
Obsessive-compulsive disorder (OCD) is a chronic and severe psychiatric disorder for which effective treatment options are limited. Structural and functional neuroimaging studies have consistently implicated the orbitofrontal cortex (OFC) and striatum in the pathophysiology of the disorder. Recent genetic evidence points to involvement of components of the excitatory synapse in the etiology of OCD. However, the transcriptional alterations that could link genetic risk to known structural and functional abnormalities remain mostly unknown. To assess potential transcriptional changes in the OFC and two striatal regions (caudate nucleus and nucleus accumbens) of OCD subjects relative to unaffected comparison subjects, we sequenced messenger RNA transcripts from these brain regions. In a joint analysis of all three regions, 904 transcripts were differentially expressed between 7 OCD versus 8 unaffected comparison subjects. Region-specific analyses highlighted a smaller number of differences, which concentrated in caudate and nucleus accumbens. Pathway analyses of the 904 differentially expressed transcripts showed enrichment for genes involved in synaptic signaling, with these synapse-associated genes displaying lower expression in OCD subjects relative to unaffected comparison subjects. Finally, we estimated that cell type fractions of medium spiny neurons were lower whereas vascular cells and astrocyte fractions were higher in tissue of OCD subjects. Together, these data provide the first unbiased examination of differentially expressed transcripts in both OFC and striatum of OCD subjects. These transcripts encoded synaptic proteins more often than expected by chance, and thus implicate the synapse as a vulnerable molecular compartment for OCD.
Conflict of interest statement
D.A.L. currently receives investigator-initiated research funding from Pfizer and Merck and serves as a consultant to Astellas. S.C.P., L.L.M., L.K., J.W., B.L.C., S.A.S., B.D., and S.E.A. declare no conflicts of interest.
Figures
References
-
- Koran LM, et al. Practice guideline for the treatment of patients with obsessive-compulsive disorder. Am. J. Psychiatry. 2007;164:5–53. - PubMed
Publication types
MeSH terms
Grants and funding
- Pittsburgh Chapter Award/Achievement Rewards for College Scientists Foundation (ARCS Foundation)
- MH104255-04/U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH)
- Breakthrough Award/International OCD Foundation (International Obsessive-Compulsive Disorder Foundation)
- Career Award for Medical Scientists/Burroughs Wellcome Fund (BWF)
- T32 NS007433/NS/NINDS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
